TrialsAlert vs Antidote: Which Antidote Alternative Is Right for You? (2026)
Research monitoring vs trial matching
By Victor Lafforgue, Founder of TrialsAlert. Last updated April 2026. TrialsAlert is our product. See our editorial policy.
TrialsAlert and Antidote are often mentioned together but they solve different problems. Antidote is a clinical trial matching service that helps patients find trials they may be eligible to enroll in today. TrialsAlert is a clinical trial monitoring service that tracks all research activity for a condition and delivers weekly plain-language briefings. If you are looking for an Antidote alternative, the question is not which one is better. It is which one matches your goal. This page compares both services honestly so you can pick the right fit.
Feature comparison
| Feature | TrialsAlert | Antidote |
|---|---|---|
| Data source | ClinicalTrials.gov API v2 (synced daily) | ClinicalTrials.gov plus direct sponsor partnerships |
| Update frequency | Scans daily; weekly briefing delivered every Friday | Continuous matching as recruiting trials appear |
| AI scoring | Six dimensions of patient-relevant impact | Eligibility-focused matching; no patient-facing impact scoring |
| Alert delivery | Weekly email briefing per tracked condition | Notifications when a new recruiting match appears |
| Pricing | From EUR 11/month (Single). EUR 19/month (Universal). 27% off quarterly. | Free for patients (sponsor-funded) |
| Patient vs researcher focus | Built exclusively for patients and caregivers | Patient-focused, with sponsor recruitment as the business model |
| Number of conditions | 400,000+ trials tracked; 1 or 3 conditions per subscription | Condition-based profile; matches as recruiting trials appear |
| Language support | English and French UI; briefings in plain English | English |
What is Antidote?
Antidote (antidote.me) is a clinical trial matching service that connects patients with trials they may be eligible to join. Patients enter their condition and health profile. Antidote's matching engine then suggests specific recruiting trials in their area. The service is free for patients because Antidote's revenue comes from pharmaceutical sponsors who pay for recruitment services. Antidote's focus is enrollment: helping patients find a trial they can participate in today. It does not track or summarize the broader clinical research landscape for a condition. It answers "What trial can I enroll in?" not "What is new in research for my condition this week?"
How is TrialsAlert different from Antidote?
The key difference is purpose. Antidote helps you find a trial to join right now. TrialsAlert helps you stay informed about all the research happening for your condition over time, including trials you cannot join but that may lead to new treatments in the future. Antidote's output is a list of recruiting trials matched to your health profile. TrialsAlert's output is a weekly plain-language briefing explaining what changed in your condition's research landscape that week, classified by impact, with doctor-ready reports you can share with your physician. These two services are often complementary. A patient might use Antidote to find a trial to join, and TrialsAlert to track the broader research landscape for their condition.
Trial matching vs condition monitoring
Trial matching services like Antidote evaluate your specific health profile (age, diagnosis, prior treatments, location, lab values) against the eligibility criteria of recruiting trials. This is valuable if you are actively seeking enrollment and want to know which trials are open to you today. Condition monitoring, which TrialsAlert provides, tracks all trials related to your condition regardless of recruitment status or your personal eligibility, and classifies them by potential impact. This gives you a broader view of the research landscape: early-phase studies that may not be recruiting yet, Phase 3 results that could change treatment standards, and late-stage programs that could lead to approved therapies in the next 1-3 years.
Who should choose Antidote
Choose Antidote if your primary goal is to enroll in a clinical trial now. Antidote's matching engine is purpose-built for that, and the free pricing makes it easy to try. If you have been told your standard treatment is no longer working, if you are facing a rare or difficult diagnosis, or if you simply want to actively participate in research, Antidote is the right first stop. The fact that it is free for patients (sponsor-funded) means there is no financial barrier to using it. Patients who are actively seeking enrollment should try Antidote and other matching services (including BreastCancerTrials.org, MJFox Trial Finder for Parkinson's, and similar condition-specific matchers) rather than paying for a monitoring service.
Who should choose TrialsAlert
Choose TrialsAlert if you want to stay informed about all the research happening for your condition, not just trials you can enroll in today. TrialsAlert is built for patients and caregivers who want ongoing research literacy. It answers questions like: "What Phase 3 trials are reading out this year for breast cancer?" or "Which new mechanisms of action are being tested in Alzheimer's?" The weekly briefing format means you do not miss what matters across a condition's research pipeline, and the doctor-ready reports give you structured material to discuss with your physician. TrialsAlert is also the right fit for caregivers tracking a family member's diagnosis.
Frequently asked questions
Does TrialsAlert help me enroll in a clinical trial?
No. TrialsAlert is a monitoring service, not a matching service. TrialsAlert surfaces trials relevant to your condition and explains what they mean. If you want to enroll in a specific trial, you can use the ClinicalTrials.gov record to contact the study team directly. Antidote and other matching services are built specifically for enrollment.
Can I use both TrialsAlert and Antidote?
Yes, and they are complementary. Antidote helps you find a trial to join today. TrialsAlert keeps you informed about research progress over time, including trials you cannot join now but that may produce new treatments later.
Is TrialsAlert worth paying for if Antidote is free?
They solve different problems. Antidote is free because sponsors pay to recruit patients. TrialsAlert is paid because it is a patient-facing subscription service with no sponsor conflicts of interest. If you want ongoing monitoring for a specific condition, TrialsAlert is the right choice. If you are actively seeking enrollment, Antidote is free and well-suited.
Does TrialsAlert share my health profile with sponsors like Antidote does?
No. TrialsAlert is a subscription service, not a recruitment platform. We do not share subscriber health data with pharmaceutical sponsors. Your condition keyword is used only to match you against ClinicalTrials.gov trial records on our servers.
The bottom line
Antidote and TrialsAlert are complementary tools, not direct competitors. If you want to enroll in a clinical trial right now, Antidote and condition-specific matching services (BreastCancerTrials.org, MJFox Trial Finder, ResearchMatch) are the right starting point. If you want ongoing research monitoring for your condition, with weekly plain-language briefings you can share with your doctor, TrialsAlert is the Antidote alternative built for that use case.